Sangart

Sangart

closed
Biopharmaceutical company developing global scientific, clinical and commercial oxygen-therapeutic agents.

Launch date
Employees
Market cap
-
Enterprise valuation
€182—273m (Dealroom.co estimates May 2012.)
San Diego California (HQ)
Authorizing premium user...